Kenneth Kwong

Last updated
Kwong, Kenneth
Born (1948-03-28) 28 March 1948 (age 75)
Citizenship United States
Alma mater University of California, Berkeley
University of California, Riverside
Known for fMRI
Scientific career
Fields Magnetic Resonance
Institutions Harvard University

Kenneth Kin Man Kwong is a Hong Kong-born American nuclear physicist. He is a pioneer in human brain imaging. He received his bachelor's degree in Political Science in 1972 from the University of California, Berkeley. He went on to receive his Ph.D. in physics from the University of California, Riverside studying photon-photon collision interactions.

Contents

Career

In 1985, Kwong was a nuclear medicine physicist at the VA hospital in Loma Linda, California, establishing his work in medical science. After one year he was invited to a research fellowship at the Massachusetts General Hospital (MGH) in the field of PET (positron emission tomography) imaging. Following his work in PET, he began his involvement in magnetic resonance imaging (MRI).

MRI, Diffusion, and Perfusion

Upon joining the team at the MGH Nuclear Magnetic Resonance (MGH-NMR) Center, Kwong pursued an interest in perfusion (the distribution of blood and nutrients to tissue) and diffusion (the detection of random dispersion of particles, principally water) in living tissues. Together with MIT graduate student Daisy Chien, and colleagues Richard Buxton, Tom Brady and Bruce Rosen he was one of the earliest entrants in the field of brain diffusion imaging, which itself was opened by the pioneering experiments of Denis Le Bihan. In a conference paper in 1988 at the Society for Magnetic Resonance in Medicine the MGH group was the first to demonstrate diffusion anisotropy in the human brain, stating, "... we observed different diffusion patterns parallel and perpendicular to the midline of the brain, which was repeatable, and depended only on the direction of diffusion encoding gradient relative to the brain, regardless of which physical gradient was used.". [1] This anisotropy itself is the fundamental principle underlying the modern method of MRI tractography and structural connectomics (the in vivo visualization the axonal fibers that connect neurons in the brain) . Chien and Kwong then used their early diffusion techniques to study human patients with stroke. In technically demanding circumstances (a low field MRI using conventional imaging, located in a parking lot trailer nearby the MGH) they were the first to demonstrate in human subjects [2] the early drop in diffusivity seen in acute infarction in cats by Moseley. [3]

Consistent with his joint appointment in the Massachusetts Eye and Ear Infirmary, he and his colleagues were able to demonstrate that MRI could be used to study diffusion and flow in the living eye. He and his colleagues pioneered the use of H2O17 as a water tracer in MRI and demonstrated that this novel approach could be used to measure brain blood flow. [4]

Functional MRI (fMRI)

In 1990, the MGH-NMR Center received the first clinical echo planar imaging (EPI) MRI instrument, capable of forming MRI images in 25 ms. The EPI method proved extremely powerful in the study of both perfusion and diffusion by allowing Kwong, and others, to evaluate dynamic changes in signal, such as the flow of blood labeled with injected magnetic contrast agents through the organ systems.

The MGH-NMR Center group, led by John (Jack) Belliveau, recognized that dynamic perfusion methods could be adapted to demonstrate perfusion changes that occur as a result of brain "work", e.g., the recruitment of localized areas of neural tissue as different parts of the brain participate in tasks. The landmark results of Belliveau, et al., in 1991, [5] using dynamic susceptibility contrast heralded the creation of a new field in functional activity mapping of the human brain using magnetic resonance imaging - fMRI.

Two parallel developments in endogenous contrast set the stage of methods to map brain activity without injection of tracers or contrast agents. Contemporaneous work a decade earlier by Thulborn, [6] and Wright at Stanford, had shown that blood oxygenation levels could be measured by NMR methods. Later groundbreaking experiments by Ogawa, et al., and by Turner had shown that oxygen depletion led to significant drops in MRI signal changes in large veins and the brain cortex itself, respectively, via a magnetic susceptibility mechanism analogous to that used by Belliveau with exogenous tracers, but in this case using deoxygenated blood itself as the contrast agent. At the same time, methods to directly measure brain perfusion using spin inverted water (arterial spin labeling) were pioneered in animal models by John Detre and Alan Koretsky. All of this was possible without the introduction of blood borne contrast agents.

With this background, Kwong reasoned that the concepts of functional mapping by brain perfusion, and the assessment of oxygenation from purely endogenous signals could be combined into an entirely new method of studying human brain activity. In the spring of 1991 he performed his first human experiments showing that large MRI signal changes were observable in the human brain following exposure to simple visual stimuli, using both blood oxygenation (BOLD) and flow contrast. The first dynamic video images of human brain activity appeared first at a meeting of the Society for Magnetic Resonance in Medicine in August 1991 in San Francisco in a plenary session by colleague Tom Brady, and was subsequently published in 1992 in the Proceedings of the National Academy of Sciences. [7] (in the same year that Ogawa and colleagues submitted their results subsequently published a year later in PNAS. [8] That same issue also included the work of Seiji Ogawa, then at Bell Labs, who had made similar findings. Most researchers credit Kwong and Ogawa independently with the discovery of what is now called Functional MRI (fMRI).

Kwong's first publication in this area, and his first experiments, demonstrated the two principal methods of functional brain imaging from endogenous signals. The oxygenation level dependent signal, known now as BOLD, has become the most popular because of its greater overall contrast/noise, but Kwong showed also that MRI could be used to detect a blood flow signal through the apparent change in T1 relaxation rates associated with the replenishment of blood in brain tissue, and demonstrated how the measured signal changes could be used to directly infer a quantitative measurement of the change in brain perfusion. This forms the basis of a second set of modern methods known now as arterial spin labeling, increasingly used when quantification of baseline and changing physiology is required. Kwong's was clearly the first work in this field to apply these methods to human brain mapping.

Functional MRI has proven extremely important in clinical and basic sciences. By February 2012 more than 299,000 manuscripts were matched by the term, "fMRI," on the PubMed database. This amounts to an average of more than 41 published manuscripts per day since the original method development 20 years earlier (24873 papers in 2011). To date no method has surpassed its combination of precision, safety and reliability in observing brain function. Kwong's discoveries were made while he was a research fellow.

Academic

In 1993, shortly after his fMRI discoveries, Kwong was made instructor in radiology. He advanced to an assistant professorship in 1997, and since 2000 has been an associate professor at the Harvard Medical School.

Continuing Research

Kwong is an active researcher, authoring or co-authoring 97 papers from 1992 to 2011, in the period following the initial fMRI publication. His most current work addresses problems in quantitative brain perfusion measurement as well as studies of brain effects of the traditional Chinese medical practice of acupuncture.

Related Research Articles

<span class="mw-page-title-main">Magnetic resonance imaging</span> Medical imaging technique

Magnetic resonance imaging (MRI) is a medical imaging technique used in radiology to form pictures of the anatomy and the physiological processes of the body. MRI scanners use strong magnetic fields, magnetic field gradients, and radio waves to generate images of the organs in the body. MRI does not involve X-rays or the use of ionizing radiation, which distinguishes it from CT and PET scans. MRI is a medical application of nuclear magnetic resonance (NMR) which can also be used for imaging in other NMR applications, such as NMR spectroscopy.

<span class="mw-page-title-main">Functional magnetic resonance imaging</span> MRI procedure that measures brain activity by detecting associated changes in blood flow

Functional magnetic resonance imaging or functional MRI (fMRI) measures brain activity by detecting changes associated with blood flow. This technique relies on the fact that cerebral blood flow and neuronal activation are coupled. When an area of the brain is in use, blood flow to that region also increases.

The first neuroimaging technique ever is the so-called 'human circulation balance' invented by Angelo Mosso in the 1880s and able to non-invasively measure the redistribution of blood during emotional and intellectual activity. Then, in the early 1900s, a technique called pneumoencephalography was set. This process involved draining the cerebrospinal fluid from around the brain and replacing it with air, altering the relative density of the brain and its surroundings, to cause it to show up better on an x-ray, and it was considered to be incredibly unsafe for patients. A form of magnetic resonance imaging (MRI) and computed tomography (CT) were developed in the 1970s and 1980s. The new MRI and CT technologies were considerably less harmful and are explained in greater detail below. Next came SPECT and PET scans, which allowed scientists to map brain function because, unlike MRI and CT, these scans could create more than just static images of the brain's structure. Learning from MRI, PET and SPECT scanning, scientists were able to develop functional MRI (fMRI) with abilities that opened the door to direct observation of cognitive activities.

<span class="mw-page-title-main">Perfusion</span> Passage of fluid through the circulatory or lymphatic system to an organ or tissue

Perfusion is the passage of fluid through the circulatory system or lymphatic system to an organ or a tissue, usually referring to the delivery of blood to a capillary bed in tissue. Perfusion is measured as the rate at which blood is delivered to tissue, or volume of blood per unit time per unit tissue mass. The SI unit is m3/(s·kg), although for human organs perfusion is typically reported in ml/min/g. The word is derived from the French verb "perfuser" meaning to "pour over or through". All animal tissues require an adequate blood supply for health and life. Poor perfusion (malperfusion), that is, ischemia, causes health problems, as seen in cardiovascular disease, including coronary artery disease, cerebrovascular disease, peripheral artery disease, and many other conditions.

Blood-oxygen-level-dependent imaging, or BOLD-contrast imaging, is a method used in functional magnetic resonance imaging (fMRI) to observe different areas of the brain or other organs, which are found to be active at any given time.

<span class="mw-page-title-main">Seiji Ogawa</span> Japanese researcher (born 1934)

Seiji Ogawa is a Japanese biophysicist and neuroscientist known for discovering the technique that underlies Functional Magnetic Resonance Imaging (fMRI). He is regarded as the father of modern functional brain imaging. He determined that the changes in blood oxygen levels cause its magnetic resonance imaging properties to change, allowing a map of blood, and hence, functional, activity in the brain to be created. This map reflected which neurons of the brain responded with electrochemical signals to mental processes. He was the first scientist who demonstrated that the functional brain imaging is dependent on the oxygenation status of the blood, the BOLD effect. The technique was therefore called blood oxygenation level-dependent or BOLD contrast. Functional MRI (fMRI) has been used to map the visual, auditory, and sensory regions and moving toward higher brain functions such as cognitive functions in the brain.

Signal enhancement by extravascular water protons, or SEEP, is a contrast mechanism for functional magnetic resonance imaging (fMRI), which is an alternative to the more commonly employed BOLD contrast. This mechanism for image contrast changes corresponding to changes in neuronal activity was first proposed by Dr. Patrick Stroman in 2001. SEEP contrast is based on changes in tissue water content which arise from the increased production of extracellular fluid and swelling of neurons and glial cells at sites of neuronal activity. Because the dominant sources of MRI signal in biological tissues are water and lipids, an increase in tissue water content is reflected by a local increase in MR signal intensity. A correspondence between BOLD and SEEP signal changes, and sites of activity, has been observed in the brain and appears to arise from the common dependence on changes in local blood flow to cause a change in blood oxygenation or to produce extracellular fluid. The advantage of SEEP contrast is that it can be detected with MR imaging methods which are relatively insensitive to magnetic susceptibility differences between air, tissues, blood, and bone. Such susceptibility differences can give rise to spatial image distortions and areas of low signal, and magnetic susceptibility changes in blood give rise to the BOLD contrast for fMRI. The primary application of SEEP to date has been fMRI of the spinal cord because the bone/tissue interfaces around the spinal cord cause poor image quality with conventional fMRI methods. The disadvantages of SEEP compared to BOLD contrast are that it reveals more localized areas of activity, and in the brain the signal intensity changes are typically lower, and it can therefore be more difficult to detect.

<span class="mw-page-title-main">Susceptibility weighted imaging</span>

Susceptibility weighted imaging (SWI), originally called BOLD venographic imaging, is an MRI sequence that is exquisitely sensitive to venous blood, hemorrhage and iron storage. SWI uses a fully flow compensated, long echo, gradient recalled echo (GRE) pulse sequence to acquire images. This method exploits the susceptibility differences between tissues and uses the phase image to detect these differences. The magnitude and phase data are combined to produce an enhanced contrast magnitude image. The imaging of venous blood with SWI is a blood-oxygen-level dependent (BOLD) technique which is why it was referred to as BOLD venography. Due to its sensitivity to venous blood SWI is commonly used in traumatic brain injuries (TBI) and for high resolution brain venographies but has many other clinical applications. SWI is offered as a clinical package by Philips and Siemens but can be run on any manufacturer’s machine at field strengths of 1.0 T, 1.5 T, 3.0 T and higher.

<span class="mw-page-title-main">Physics of magnetic resonance imaging</span> Overview article

The physics of magnetic resonance imaging (MRI) concerns fundamental physical considerations of MRI techniques and technological aspects of MRI devices. MRI is a medical imaging technique mostly used in radiology and nuclear medicine in order to investigate the anatomy and physiology of the body, and to detect pathologies including tumors, inflammation, neurological conditions such as stroke, disorders of muscles and joints, and abnormalities in the heart and blood vessels among others. Contrast agents may be injected intravenously or into a joint to enhance the image and facilitate diagnosis. Unlike CT and X-ray, MRI uses no ionizing radiation and is, therefore, a safe procedure suitable for diagnosis in children and repeated runs. Patients with specific non-ferromagnetic metal implants, cochlear implants, and cardiac pacemakers nowadays may also have an MRI in spite of effects of the strong magnetic fields. This does not apply on older devices, and details for medical professionals are provided by the device's manufacturer.

Robert Turner is a British neuroscientist, physicist, and social anthropologist. He has been a director and professor at the Max Planck Institute for Human Cognitive and Brain Sciences in Leipzig, Germany, and is an internationally recognized expert in brain physics and magnetic resonance imaging (MRI). Coils inside every MRI scanner owe their shape to his ideas.

<span class="mw-page-title-main">Magnetic resonance imaging of the brain</span>

Magnetic resonance imaging of the brain uses magnetic resonance imaging (MRI) to produce high quality two-dimensional or three-dimensional images of the brain and brainstem as well as the cerebellum without the use of ionizing radiation (X-rays) or radioactive tracers.

Mark Steven Cohen is an American neuroscientist and early pioneer of functional brain imaging using magnetic resonance imaging. He currently is a Professor of Psychiatry, Neurology, Radiology, Psychology, Biomedical Physics and Biomedical Engineering at the Semel Institute for Neuroscience and Human Behavior and the Staglin Center for Cognitive Neuroscience. He is also a performing musician.

<span class="mw-page-title-main">Intravoxel incoherent motion</span>

Intravoxel incoherent motion (IVIM) imaging is a concept and a method initially introduced and developed by Le Bihan et al. to quantitatively assess all the microscopic translational motions that could contribute to the signal acquired with diffusion MRI. In this model, biological tissue contains two distinct environments: molecular diffusion of water in the tissue, and microcirculation of blood in the capillary network (perfusion). The concept introduced by D. Le Bihan is that water flowing in capillaries mimics a random walk (Fig.1), as long as the assumption that all directions are represented in the capillaries is satisfied.

Arno Villringer is a Director at the Department of Neurology at the Max Planck Institute for Human Cognitive and Brain Sciences in Leipzig, Germany; Director of the Department of Cognitive Neurology at University of Leipzig Medical Center; and Academic Director of the Berlin School of Mind and Brain and the Mind&Brain Institute, Berlin. He holds a full professorship at University of Leipzig and an honorary professorship at Charité, Humboldt-Universität zu Berlin. From July 2022 to June 2025 he is the Chairperson of the Human Sciences Section of the Max Planck Society.

Functional magnetic resonance spectroscopy of the brain (fMRS) uses magnetic resonance imaging (MRI) to study brain metabolism during brain activation. The data generated by fMRS usually shows spectra of resonances, instead of a brain image, as with MRI. The area under peaks in the spectrum represents relative concentrations of metabolites.

<span class="mw-page-title-main">Perfusion MRI</span>

Perfusion MRI or perfusion-weighted imaging (PWI) is perfusion scanning by the use of a particular MRI sequence. The acquired data are then post-processed to obtain perfusion maps with different parameters, such as BV, BF, MTT and TTP.

Bruce Rosen is an American physicist and radiologist and a leading expert in the area of functional neuroimaging. His research for the past 30 years has focused on the development and application of physiological and functional nuclear magnetic resonance techniques, as well as new approaches to combine functional magnetic resonance imaging (fMRI) data with information from other modalities such as positron emission tomography (PET), magnetoencephalography (MEG) and noninvasive optical imaging. The techniques his group has developed to measure physiological and metabolic changes associated with brain activation and cerebrovascular insult are used by research centers and hospitals throughout the world.

The history of magnetic resonance imaging (MRI) includes the work of many researchers who contributed to the discovery of nuclear magnetic resonance (NMR) and described the underlying physics of magnetic resonance imaging, starting early in the twentieth century. MR imaging was invented by Paul C. Lauterbur who developed a mechanism to encode spatial information into an NMR signal using magnetic field gradients in September 1971; he published the theory behind it in March 1973. The factors leading to image contrast had been described nearly 20 years earlier by physician and scientist Erik Odeblad and Gunnar Lindström. Among many other researchers in the late 1970s and 1980s, Peter Mansfield further refined the techniques used in MR image acquisition and processing, and in 2003 he and Lauterbur were awarded the Nobel Prize in Physiology or Medicine for their contributions to the development of MRI. The first clinical MRI scanners were installed in the early 1980s and significant development of the technology followed in the decades since, leading to its widespread use in medicine today.

<span class="mw-page-title-main">MRI sequence</span>

An MRI sequence in magnetic resonance imaging (MRI) is a particular setting of pulse sequences and pulsed field gradients, resulting in a particular image appearance.

Arterial spin labeling (ASL), also known as arterial spin tagging, is a magnetic resonance imaging technique used to quantify cerebral blood perfusion by labelling blood water as it flows throughout the brain. ASL specifically refers to magnetic labeling of arterial blood below or in the imaging slab, without the need of gadolinium contrast. A number of ASL schemes are possible, the simplest being flow alternating inversion recovery (FAIR) which requires two acquisitions of identical parameters with the exception of the out-of-slice saturation; the difference in the two images is theoretically only from inflowing spins, and may be considered a 'perfusion map'. The ASL technique was developed by Alan P. Koretsky, Donald S. Williams, John A. Detre and John S. Leigh, Jr in 1992.

References

  1. Chien, D; Buxton, RB; Kwong, KK; Brady, TJ; Rosen, BR (1990). "MR diffusion imaging of the human brain". J Comput Assist Tomogr. 14 (4): 514–520. doi:10.1097/00004728-199007000-00003. PMID   2370348. S2CID   102556.
  2. Chien, D; Kwong, KK; Buonanno, F; Buxton, R; Gress, D; Brady, TJ; Rosen, BR (1992). "MR diffusion imaging of cerebral infarction in humans". AJNR. 13 (4): 1097–1102. PMC   8333580 . PMID   1636519.
  3. Moseley, ME; Cohen, Y; Mintorovitch, J; Chileuitt, L; Shimizu, H; Kucharczyk, J; Wendland, MF; Weinstein, PR (1990). "Early detection of regional cerebral ischemia in cats: comparison of diffusion- and T2-weighted MRI and spectroscopy". Magnetic Resonance in Medicine. 14 (2): 330–346. doi:10.1002/mrm.1910140218. PMID   2345513. S2CID   23754356.
  4. Kwong, KK; Hopkins, AL; Belliveau, JW; Chesler, DA; Porkka, LM; McKinstry, RC; Finelli, DA; Hunter, GJ; Moore, JB; et al. (1991). "Proton NMR imaging of cerebral blood flow using (H2O)-O17". Magnetic Resonance in Medicine. 22 (1): 154–158. doi:10.1002/mrm.1910220116. PMID   1798389. S2CID   46361573.
  5. Belliveau JW, Kennedy DN, McKinstry RC, Buchbinder BR, Weisskoff RM, Cohen MS, Vevea JM, Brady TJ, Rosen BR (1991). "Functional mapping of the human visual cortex by magnetic resonance imaging". Science . 254 (5032): 716–719. Bibcode:1991Sci...254..716B. doi:10.1126/science.1948051. PMID   1948051.
  6. Thulborn, KR; Waterton, JC; Matthews, PM; Radda, GK (1982). "Oxygenation dependence of the transverse relaxation time of water protons in whole blood at high field". Biochim Biophys Acta. 714 (2): 265–270. doi:10.1016/0304-4165(82)90333-6. PMID   6275909.
  7. KK Kwong; JW Belliveau; DA Chesler; IE Goldberg; RM Weisskoff; BP Poncelet; DN Kennedy; BE Hoppel; MS Cohen; R Turner; H Cheng; TJ Brady; and BR Rosen (1992). "Dynamic Magnetic Resonance Imaging of Human Brain Activity During Primary Sensory Stimulation". PNAS . 89 (12): 5951–55. Bibcode:1992PNAS...89.5675K. doi: 10.1073/pnas.89.12.5675 . PMC   49355 . PMID   1608978.
  8. S Ogawa; Tank; Menon; Ellermann; Kim; Merkle; Ugurbil (1992). "Intrinsic signal changes accompanying sensory stimulation: Functional brain mapping with magnetic resonance imaging". PNAS . 89 (13): 5675–79. Bibcode:1992PNAS...89.5951O. doi: 10.1073/pnas.89.13.5951 . PMC   402116 . PMID   1631079.